Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study
Table 2
Association of HbA1c values with GP satisfaction of glycaemic control and with treatment types among all included patients (N = 268).
Mean HbA1c % (SE)*
GP satisfied with glycaemic control
6.7 (0.9)
Treatment prescribed
Monotherapy
6.6 (0.6)
Bitherapy
6.9 (0.8)
Tritherapy
7.0 (1.4)
Insulin + oral anti-diabetic
7.2 (1.2)
Insulin
7.4 (2.7)
Group
Group 1 (N = 75)
6.9 (0.9)
Group 2 (N = 193)
6.7 (0.9)
GP not satisfied with glycaemic control
8.2 (1.4)
Group
Group 1 (N = 75)
8.3 (1.3)
Group 2 (N = 193)
8.2 (1.5)
Based on last measure of HbA1c. SE: standard error.
